Figure S1. Cohort selection. Breast cancer cohort selection workflow visualized. Figure S2. Prognostic value of FFAR4 in different breast cancer subtypes. (PDF 139âkb
Table S3. Differentially expressed genes in MM134 and SUM44 long-term estrogen deprivation (LTED) ce...
Table S1. Circulating concentrations of OPG and risk of death following a breast cancer diagnosis, b...
Table S1. Multivariate Cox proportional hazards model analysis for Fig. 1b-h. (PDF 401 kb
Table S1. Fatty Acid Quantities in Normal and Cancerous Breast Tissues. Table S2. Fatty Acid Proport...
Figure S2. Expression of CPT1A lower in ER-negative, relative to ER-positive breast cancer cell line...
Figure S1. Age-adjusted overall survival by breast cancer molecular subtypesa. a Luminal A - ER posi...
A list of targeted lipid metabolites in this study. The lipid metabolites targeted in this study wer...
Multivariate analysis including Estrogen and Her2 receptor status. This additional file comprises 3 ...
Figure S2. Age-adjusted breast cancer-free interval by breast cancer molecular subtypesa. a Luminal ...
Table S1. Clinical characteristics of the patients with breast cancer and histopathological characte...
Table S2. Multivariable adjusted Cox proportional hazard ratios (HRs) for overall mortality and brea...
Table S1. Published gene expression datasets analysed in this study. (XLSX 10Â kb
Figure S3. (A). Relative mRNA expression levels of FABP4, FABP5 and CD36 in breast cancer cell lines...
Figure S2. Representative immunohistochemical staining of ATGL in normal breast and tumor tissues. (...
Figure S1. FAO signature expression is not associated with ovarian cancer overall survival from the ...
Table S3. Differentially expressed genes in MM134 and SUM44 long-term estrogen deprivation (LTED) ce...
Table S1. Circulating concentrations of OPG and risk of death following a breast cancer diagnosis, b...
Table S1. Multivariate Cox proportional hazards model analysis for Fig. 1b-h. (PDF 401 kb
Table S1. Fatty Acid Quantities in Normal and Cancerous Breast Tissues. Table S2. Fatty Acid Proport...
Figure S2. Expression of CPT1A lower in ER-negative, relative to ER-positive breast cancer cell line...
Figure S1. Age-adjusted overall survival by breast cancer molecular subtypesa. a Luminal A - ER posi...
A list of targeted lipid metabolites in this study. The lipid metabolites targeted in this study wer...
Multivariate analysis including Estrogen and Her2 receptor status. This additional file comprises 3 ...
Figure S2. Age-adjusted breast cancer-free interval by breast cancer molecular subtypesa. a Luminal ...
Table S1. Clinical characteristics of the patients with breast cancer and histopathological characte...
Table S2. Multivariable adjusted Cox proportional hazard ratios (HRs) for overall mortality and brea...
Table S1. Published gene expression datasets analysed in this study. (XLSX 10Â kb
Figure S3. (A). Relative mRNA expression levels of FABP4, FABP5 and CD36 in breast cancer cell lines...
Figure S2. Representative immunohistochemical staining of ATGL in normal breast and tumor tissues. (...
Figure S1. FAO signature expression is not associated with ovarian cancer overall survival from the ...
Table S3. Differentially expressed genes in MM134 and SUM44 long-term estrogen deprivation (LTED) ce...
Table S1. Circulating concentrations of OPG and risk of death following a breast cancer diagnosis, b...
Table S1. Multivariate Cox proportional hazards model analysis for Fig. 1b-h. (PDF 401 kb